Rayner Newsroom

14 September, 2017. Rayner are proud to announce the launch of the newest member of the RayOne® family of preloaded IOLs: the RayOne® Trifocal, to be unveiled at the upcoming 2017 ESCRS conference in Lisbon.

Product availability will be from 9 October 2017 to all CE registered markets.

Rayner are proud to announce the launch of RayOne^®: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen, following the recent receipt of CE mark approval.

This flagship launch is the second in the pipeline of 11 new products which Rayner plan to launch over the next 3 years, a testament to Rayner’s renewed commitment to transform into one of the leading manufacturers of IOLs, all with the ambition of delivering better patient outcomes.

Introducing Ophteis^® FR Pro with sorbitol – for unparalleled Free Radical Scavenging (FRS)

On March 7th 2016, Rayner launches a new OVD – Ophteis^® FR Pro . Ophteis^® FR Pro with sorbitol is a revolution in OVDs, protecting the corneal endothelium from free radical energy caused by phaco emulsification.

The next step in the evolution of cataract surgery?

...

The recent Jan Venter (MD, Clinic Director of the Optical Express International Medical Advisory Board) article provides further evidence of the predictability of the Sulcoflex® Aspheric in correcting refractive surprises.

Residual refractive error has a major impact on patient satisfaction, and lens exchange or excimer laser may not be a viable option to correct ametropia in these dissatisfied patients. Dr Venter’s paper provides evidence of the effectiveness of Sulcoflex Aspheric in correcting these refractive surprises in a large cohort of patients (80 eyes in 64 patients). 

Rayner proudly announced today that the T-flex Aspheric Toric intraocular lens (IOL) has received Chinese Food and Drug Administration (CFDA) approval and is being launched in China.

Product Approval Details

The CFDA granted regulatory approval and sale of the T-flex Aspheric Toric IOL (623T) in the following power range:

Spheres: -10.0 to +24.0 D in 0.5 D steps
Cylinders: +1.0 to +11.0 D in 0.5 D steps

Rayner announces the launch of its new injector RaySert®PLUS designed for safe and effective implantations through a 2.2mm wound assisted mini incision.

Rayner announces that registration of the Sulcoflex® Aspheric has been approved by the Korean Food and Drugs Administration, and will now be available for sale in the Republic of Korea. In addition to the C-flex® and Superflex® spherical/aspheric monofocal IOLs, eye surgeons will now be able to offer patients an effective, reversible option for the resolution of post-operative myopic or hypermetropic refractive surprises.

Rayner Intraocular Lens Limited, the pioneering manufacturer of intraocular lenses, today announces the launch of the company’s first preloaded IOL product - C-flex®Advance Aspheric - at the XXXI European Society of Cataract and Refractive Surgeons Meeting, in Amsterdam, The Netherlands.

Rayner today announced from the XXV Congress of the European Society of Cataract and Refractive Surgeons (ESCRS) the launch of a new lens in the European and Asian markets: the Sulcoflex® Single Piece intraocular lens (IOL).

British IOL manufacturer, Rayner Intraocular Lenses Ltd., proudly announced today that it recently attained the coveted Therapeutic Goods Administration (TGA) clearance for sale of its intraocular lenses (IOLs) in Australia.

Rayner’s lenses are the first European IOLs to get TGA approval in over a decade. The TGA’s strict requirements over the years tended to restrict entry of new IOLs to Australia. This limited choice is about to change with Rayner’s entry into the market with the C-flex® injectable acrylic IOL system.